[Federal Register Volume 62, Number 32 (Tuesday, February 18, 1997)]
[Notices]
[Page 7245]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-3937]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health; National Cancer Institute
Notice of Meeting of the National Cancer Advisory Board and its
Subcommittees Pursuant to Public Law 92-463, notice is hereby given of
the meeting of the National Cancer Advisory Board, National Cancer
Institute, and its Subcommittees on February 24-26, 1997. The meetings
of the Board and its Subcommittees will be open to the public as
indicated below. Attendance by the public will be limited to space
available.
A portion of the Board meeting will be closed to the public in
accordance with the provisions set forth in secs. 552b(c)(4),
552b(c)(6), and 552(c)(9)(B), Title 5, U.S.C. and sec. 10(d) of Public
Law 92-463, for the review, discussion and evaluation of individual
grant applications and for discussion of issues pertaining to
programmatic areas and/or NCI personnel. These applications and
discussions could reveal confidential trade secrets or commercial
property such as patentable material, and personal information
concerning the individuals associated with the applications or
programs, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy and premature disclosure of
recommendations which would inhibit the final outcome and subsequent
implementation of recommendations.
The Committee Management Office, National Cancer Institute,
National Institutes of Health, Executive Plaza North, Room 630E, 6130
Executive Boulevard, MSC 7410, Rockville, Maryland 20892-7410, (301)
496-5708 will provide summaries of the meetings and rosters of the
Board members, upon request.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
contact Ms. Cynthia Morgan, Committee Management Specialist, at (301)
496-5708 in advance of the meeting.
Name of Committee: Ad Hoc Subcommittee on Policy and Advocacy.
Contact Person: Dr. Marvin R. Kalt, Executive Secretary,
National Cancer Institute, NIH, Executive Plaza North, Room 600,
6130 Executive Blvd., MSC 7405, Bethesda, MD 20892-7405, (301) 496-
5147.
Date of Meeting: February 24, 1997.
Place of Meeting: Hyatt Regency Bethesda, One Bethesda Metro
Center, Bethesda, MD 20814.
Open: 7:00 pm to 9:00 pm.
Agenda: To discuss the role of the NCAB in advocacy activities
and in advising NCI on extramural and intramural policy.
Name of Committee: Subcommittee on Cancer Centers.
Contact Person: Dr. Brian Kimes, Executive Secretary, National
Cancer Institute, NIH, Executive Plaza North, Room 502, 6130
Executive Blvd., MSC 7383, Bethesda, MD 20892-7383, (301) 496-8537.
Date of Meeting: February 24, 1997.
Place of Meeting: Hyatt Regency Bethesda, One Bethesda Metro
Center, Bethesda, MD 20814.
Open: 7:00 pm to 9:00 pm.
Agenda: To discuss new Cancer Centers guidelines.
Name of Committee: Subcommittee on Planning and Budget.
Contact Person: Ms. Cherie Nichols, Executive Secretary,
National Cancer Institute, NIH, 7550 Wisconsin Avenue, Room 312, MSC
9010, Bethesda, MD 20892-9010, (301) 496-5515.
Date of Meeting: February 25, 1997.
Place of Meeting: Conference Room 10, Building 31C, National
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
Open: 1:15 pm to 2:30 pm.
Agenda: To discuss the NCI Budget and various planning issues.
Name of Committee: Subcommittee on Special Actions for Grants.
Contact Person: Dr. Marvin R. Kalt, Executive Secretary,
National Cancer Institute, NIH, Executive Plaza North, Room 600,
6130 Executive Blvd., MSC 7405, Bethesda, MD 20892-7405, (301) 496-
5147.
Date of Meeting: February 25, 1997.
Closed: 3:45 to approximately 5:00 pm.
Place of Meeting: Conference Room 10, Building 31C, National
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892
Agenda: For review and discussion of individual grant
applications.
Name of Committee: National Cancer Advisory Board.
Contact Person: Dr. Marvin R. Kalt, Executive Secretary,
National Cancer Institute, NIH, Executive Plaza North, Room 600,
6130 Executive Blvd., MSC 7405, Bethesda, MD 20892-7405, (301) 496-
5147.
Dates of Meeting: February 25-26, 1997.
Place of Meeting: Conference Room 10, Building 31C, National
Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.
Open: February 25--8:30 am to approximately 1:15 pm; February
25--2:30 pm to approximately 3:45 pm; February 26--8:30 am to
adjournment.
Agenda: Report of the Director, National Cancer Institute;
Reports from the Association of Community Cancer Centers and
American Association for Cancer Research; Subcommittee Reports
including Global Programs at Cancer Centers and Cancer Center
Guidelines; Report of the Director, Division of Research Grants;
Discussion of Mammography Guidelines; Discussion of President's
Cancer Panel Report on Managed Health Care; and other Council
business.
Closed: February 25--5:00 pm to adjournment.
Agenda: For review and discussion of grant applications and
extramural/intramural programmatic and personnel policies.
This notice is being published less than 15 days prior to the
meeting due to the urgent need to meet timing limitations imposed by
the review and funding cycle.
(Catalog of Federal Domestic Assistance Program Numbers: 93.393,
Cancer Cause and Prevention Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396,
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398,
Cancer Research Manpower; 93.399, Cancer Control.)
Dated: February 10, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-3937 Filed 2-14-97; 8:45 am]
BILLING CODE 4140-01-M
